MedTrace Logo

Development and Evaluation of an Evidence-based Education Program for People With Hand Dysfunction in Scleroderma

NCT06697561 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-11-20

No results posted yet for this study

Summary

The purpose of this study is to develop an evidence-based educational program for scleroderma patients with hand dysfunction. The program includes a self-care handbook and multimedia video resources. The study aims to answer:

Does the intervention improve hand function in the experimental group compared to the control group? Does the intervention improve self-care knowledge of hand dysfunction? Does the intervention improve overall health?

Participants will receive an 8-week program, while the control group receives usual care. Outcome measures include hand function, overall health, and self-care knowledge.

Conditions

  • Scleroderma, Systemic

Interventions

BEHAVIORAL

patient education program

The intervention for the experimental group was an "evidence-based educational program for hand dysfunction in patients with systemic sclerosis," which included a health education manual and multimedia videos developed through evidence translation. Additionally, individual education and consultation were provided.

Sponsors & Collaborators

  • Cheng Hsin Rehabilitation Medical Center

    collaborator OTHER

  • National Taipei University of Nursing and Health Sciences

    collaborator OTHER

  • Wen-Shao Lin

    lead OTHER

Principal Investigators

  • Cheng Hsin General Hospital · Institutional Review Board

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-30
Primary Completion
2025-06-30
Completion
2025-07-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06697561 on ClinicalTrials.gov